Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma

NCT00075452 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: oxaliplatin

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group